These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22306332)

  • 1. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
    Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
    J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.
    Hirobe S; Azukizawa H; Matsuo K; Zhai Y; Quan YS; Kamiyama F; Suzuki H; Katayama I; Okada N; Nakagawa S
    Pharm Res; 2013 Oct; 30(10):2664-74. PubMed ID: 23775442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
    Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
    Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.
    Matsuo K; Hirobe S; Yokota Y; Ayabe Y; Seto M; Quan YS; Kamiyama F; Tougan T; Horii T; Mukai Y; Okada N; Nakagawa S
    J Control Release; 2012 Jun; 160(3):495-501. PubMed ID: 22516091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
    Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
    Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
    Zhao X; Li X; Zhang P; Du J; Wang Y
    J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
    van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
    Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative freeze-drying technique in the fabrication of dissolving microneedle patch: Enhancing transdermal drug delivery efficiency.
    Su T; Tang Z; Hu J; Zhu Y; Shen T
    Drug Deliv Transl Res; 2024 Nov; 14(11):3112-3127. PubMed ID: 38431532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
    Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
    Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
    Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
    Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.
    Ding Z; Verbaan FJ; Bivas-Benita M; Bungener L; Huckriede A; van den Berg DJ; Kersten G; Bouwstra JA
    J Control Release; 2009 May; 136(1):71-8. PubMed ID: 19331846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
    Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
    Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat.
    Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    J Control Release; 2011 Jan; 149(1):15-20. PubMed ID: 20493218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.